| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 02/21/2013 | US20130045955 Novel compounds |
| 02/21/2013 | CA2845630A1 Amino quinazolines as kinase inhibitors |
| 02/21/2013 | CA2844748A1 N-(5-fluoro-2((4-methylbenzyl)oxy)pyrimidin-4-yl)benzamide derivatives |
| 02/21/2013 | CA2844091A1 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections |
| 02/21/2013 | CA2843083A1 Anthranilamide compounds and their use as pesticides |
| 02/20/2013 | EP2559687A1 Mesoionic pesticides |
| 02/20/2013 | EP2557925A1 Co -crystals of pyrimethanil or cyprodinil |
| 02/20/2013 | CN102936225A Method for preparing rosuvastatin calcium intermediate containing brooethyl, hydroxymethyl or formyl |
| 02/20/2013 | CN102936224A Preparation method of 4, 6-dichloropyrimidine |
| 02/20/2013 | CN101772489B Amine salts of a CRTH2 antagonist |
| 02/20/2013 | CN101541789B Hydantoin derivatives used as mmp inhibitors |
| 02/20/2013 | CN101351451B Multicyclic amino acid derivatives and methods of their use |
| 02/20/2013 | CN101277700B Pyrimidine compounds as serotonin receptor modulators |
| 02/19/2013 | US8377948 Antitumor agents and methods of their use |
| 02/19/2013 | US8377943 2,4-diaminopyrimidine derivates as PTK2-inhibitors for the treatment of abnormal cell growth |
| 02/19/2013 | US8377942 Isoxazolines derivatives and their use as pesticide |
| 02/19/2013 | US8377941 Indoles as modulators of nicotinic acetylcholine receptor subtype alpha-7 |
| 02/19/2013 | US8377937 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| 02/19/2013 | US8377935 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase |
| 02/19/2013 | CA2612587C Process for preparing amorphous rosuvastatin calcium free of impurities |
| 02/19/2013 | CA2574406C Method for the production of 3-phenyl(thio)uracils and dithiouracils |
| 02/19/2013 | CA2573371C Pyrimidines as plk inhibitors |
| 02/14/2013 | WO2013022047A1 Cyclopropaneamine compound |
| 02/14/2013 | WO2013021276A1 Trpv1 antagonists including dihydroxy substituent and uses thereof |
| 02/14/2013 | WO2013020461A1 Preparation method for gefitinib intermediate |
| 02/14/2013 | WO2012150606A3 A process for preparing stable polymophic form of erlotinib hydrochloride |
| 02/14/2013 | US20130040975 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/14/2013 | CA2844525A1 Cyclopropaneamine compound |
| 02/13/2013 | EP2556081A2 A cytosine analogue, a method of preparation of a cytosine analogue, a dna methyltransferase 1 inhibitor, a method for dna methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal dna methylation |
| 02/13/2013 | CN102933585A CARBA-nucleoside synthesis and novel intermediate compounds useful therein |
| 02/13/2013 | CN102933560A 4,6-dibenzamido-2-methyl-pyridine derivatives and applications to cancer treatment |
| 02/13/2013 | CN102933559A Optically active dibenzylamine derivative, and manufacturing method for same |
| 02/13/2013 | CN102933558A Reverse amide compounds as protein deacetylase inhibitor and methods of use thereof |
| 02/13/2013 | CN102933531A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 02/13/2013 | CN102924456A Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives |
| 02/13/2013 | CN102924387A 4-(3-chloro-4-methoxyanilino)-6-(3,4-substituted phenyl)quinazoline and salts thereof, preparation method and applications |
| 02/13/2013 | CN102115463B Method for synthesizing 4,6-dihydroxy pyrimidine |
| 02/12/2013 | US8372981 Nitrogen-containing aromatic derivatives |
| 02/12/2013 | US8372975 Liquid crystal compound having difluoropropenyleneoxy bonding group |
| 02/12/2013 | US8372974 Regioselective preparation of substituted pyrimidines |
| 02/12/2013 | US8372972 Process for the preparation of dihydroquinazolines |
| 02/12/2013 | US8372970 8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders |
| 02/12/2013 | US8372858 Compounds and compositions as protein kinase inhibitors |
| 02/12/2013 | US8372855 Cyclohexyloxy-substituted heterocyclics, medicines containing these compounds and method for the production thereof |
| 02/12/2013 | US8372849 Heterocyclic compounds |
| 02/12/2013 | US8372848 N-benzylamino cyclic thioureas; obesity and related disorders; (N-(3-{(4S)-1-[(1S)-2-(benzylamino)-1-methylethyl]-3-[2-(3-fluorophenyl)ethyl]-2-thioxoimidazolidin-4-yl}propyl)guanidine |
| 02/12/2013 | US8372839 Bipartite inhibitors of bacterial RNA polymerase |
| 02/12/2013 | CA2707105C Inhibitors of stearoyl-coa desaturase |
| 02/12/2013 | CA2477350C Novel crystalline forms of the anti-cancer compound zd1839 |
| 02/07/2013 | WO2013019967A1 Modulators of virus assembly as antiviral agents |
| 02/07/2013 | WO2012111579A9 Light-emitting element |
| 02/07/2013 | US20130035485 Process for the preparation and purification of etravirine and intermediates thereof |
| 02/07/2013 | US20130035350 Novel Quinazoline Derivatives |
| 02/07/2013 | US20130035346 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 02/07/2013 | US20130035326 Biaryl compounds and methods of use thereof |
| 02/07/2013 | US20130035312 Cathepsin cysteine protease inhibiors |
| 02/07/2013 | US20130032764 Materials for organic electroluminescence devices |
| 02/06/2013 | EP2554542A1 Phenylalanine derivative salt crystal |
| 02/06/2013 | EP2554540A2 3-Cyclyl-2-(4-sulfamoyl-phenyl)-n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
| 02/06/2013 | EP2552915A1 Compounds and method for treatment of hiv |
| 02/06/2013 | CN102911126A Synthesis of 2-aryl quinazolone from benzyl halide and 2-amobenzamide |
| 02/06/2013 | CN102911125A Method for preparing gefitinib intermediate |
| 02/06/2013 | CN102911124A Hydroxy-pyrimidone compound and preparation method and application thereof |
| 02/06/2013 | CN102911123A Preparation method of 2-chloro trifluoromethyl pyrimidine compound |
| 02/06/2013 | CN102153516B Intermediate for preparing pyrimidinecarboxylic acids |
| 02/06/2013 | CN101522642B Process for preparing 6-phen0xypyrimidin-4-ol derivatives in the presence of a quinuclidine or a n-methyl pyrrolidine derivative |
| 02/05/2013 | US8367825 Substituted pyrimidinyl oxime kinase inhibitors |
| 02/05/2013 | US8367824 Process for producing quinazolin-4-one derivative |
| 02/05/2013 | US8367686 Heterocycle compounds and uses thereof |
| 02/05/2013 | US8367682 Pyrimidine derivatives and their use as pesticides |
| 02/05/2013 | US8367680 Antibacterial small molecules and methods for their synthesis |
| 02/05/2013 | US8367669 Inhibitors of hemeprotein-catalyzed lipid peroxidation |
| 02/05/2013 | US8367038 Therameutin modulators |
| 02/05/2013 | CA2591033C Heterocyclic aspartyl protease inhibitors |
| 02/05/2013 | CA2547617C Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 01/31/2013 | WO2013016488A1 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 01/31/2013 | WO2013014569A1 Quinolinyl glucagon receptor modulators |
| 01/31/2013 | WO2013013640A1 Quinazoline derivative, preparation method therefor, intermediate, composition and application thereof |
| 01/31/2013 | WO2012146736A4 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease |
| 01/31/2013 | US20130030176 Processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine |
| 01/31/2013 | US20130030171 Pyrimidinyl Aryl Urea Derivatives being FGF Inhibitors |
| 01/31/2013 | US20130030011 Compounds for the reduction of beta-amyloid production |
| 01/31/2013 | US20130029988 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 01/31/2013 | US20130029987 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith |
| 01/31/2013 | US20130029981 Compounds, compositions, and methods for controlling biofilms |
| 01/31/2013 | US20130029942 Compounds and therapeutical uses thereof |
| 01/31/2013 | CA2841981A1 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 01/31/2013 | CA2841237A1 Quinolinyl glucagon receptor modulators |
| 01/30/2013 | EP2550269A1 Process and intermediates for preparing lapatinib |
| 01/30/2013 | EP2550256A1 Process for the preparation of bosentan |
| 01/30/2013 | CN102898386A Quinazoline derivative, preparation method, intermediate, composition and application |
| 01/30/2013 | CN102898385A Synthesis of 4(3H)-quinazolone through catalysis of recyclable copper oxide |
| 01/30/2013 | CN102898384A Intermediate for preparing gefitinib and preparation method of |
| 01/30/2013 | CN102898383A Method for preparing ambroxol trans-impurity 6,8-dibromo-3-(trans-4-hydroxycyclohexyl)-1,2,3,4-tetrahydroquiazoline |
| 01/30/2013 | CN102898382A Method for synthesizing 2-amino-4,6-dimethoxypyrimidine |
| 01/30/2013 | CN102898381A Amine salts of a CRTH2 antagonist |
| 01/30/2013 | CN102898380A Amine salts of a CRTH2 antagonist |
| 01/30/2013 | CN102898379A N-(4-(4-(3-chlorphenyl)piperazino-1-yl)pyrimidyl-2-yl)amide or its salts, and preparation method and use thereof |
| 01/30/2013 | CN101528681B New sulfonamide derivatives as bradykinin antagonists |
| 01/29/2013 | US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression |